Retatrutide — Research Peptide (Lyophilised, HPLC ≥99%)

A 39-residue synthetic triple GIP/GLP-1/glucagon receptor agonist peptide supplied as a lyophilised powder for in-vitro metabolic research. Manufactured by solid-phase synthesis, purified by preparative reverse-phase HPLC and lyophilised under nitrogen. Batch-specific Certificate of Analysis on request. For laboratory research use only — not for human consumption.